Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives

Fig. 5

a Schematic representation, and b In vivo antitumor study in nude mice xenograft models of triple-responsive drug release from AuNR-HA−ALA/Cy7.5-HER2 for HER2/CD44 dual-targeted and fluorescence imaging-guided combined PDT/PTT treatment of breast cancer showing photothermal photographs, digital photos of mice bearing tumors, tumor temperature, tumor volume, tumor weight, and H&E stained micrographs of tumor tissues. Reproduced with permission from [186]. Copyright ©2019, Elsevier

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us